Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enemas are hypertonic saline solutions used as osmotic laxatives for bowel cleansing prior to procedures or for the treatment of occasional constipation.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., sigmoidoscopy, colonoscopy)
* Treatment of occasional constipation
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) enema administered as a single dose, usually within 2-5 hours before the procedure.
* **Constipation:** One 2.25 oz (66 mL) enema administered as a single dose. Repeat dose is not recommended within 24 hours.
## Pediatric Dosing
* **Constipation:**
* Ages 6-11 years: One 2.25 oz (66 mL) enema administered as a single dose.
* Ages <6 years: Use is generally not recommended due to increased risk of electrolyte imbalances and dehydration. Consult product labeling or local protocol if use is considered.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment, but caution and close monitoring are advised due to the risk of electrolyte disturbances.
## Contraindications
* Congenital or acquired megacolon
* Gastrointestinal obstruction or perforation
* Ileus
* Severe renal impairment (CrCl <30 mL/min)
* Congestive heart failure
* Known hypersensitivity to sodium phosphate
* Patients on medications that may affect renal function (e.g., NSAIDs, diuretics, ACE inhibitors)
* Children < 6 years of age (due to increased risk of toxicity)
* Patients with inadequate fluid intake or dehydration
* Patients with cardiac arrhythmias
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation, diarrhea.
* **Serious:**
* **Electrolyte abnormalities:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. This can lead to tetany, cardiac arrhythmias, and seizures.
* **Renal injury:** Acute kidney injury, especially in patients with pre-existing renal disease or those taking nephrotoxic agents.
* **Dehydration**
* **Severe gastrointestinal events:** Rectal bleeding, perforation, ulceration, ischemic colitis.
## Key Drug Interactions
* **Diuretics, ACE inhibitors, ARBs, NSAIDs:** Increased risk of renal impairment and electrolyte disturbances.
* **Drugs prolonging QT interval:** Potential additive effects with electrolyte disturbances.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., dizziness, muscle cramps, confusion, palpitations).
* Assess renal function (serum creatinine, BUN) and electrolytes (phosphate, calcium, sodium, potassium) as clinically indicated, especially in patients with risk factors.
## Clinical Pearls
* Advise patients to read and follow all instructions carefully.
* Ensure adequate fluid intake before and after administration.
* Administer the enema slowly and retain for the recommended time (usually 5-15 minutes) for maximum effectiveness.
* Due to the risk of severe electrolyte disturbances and renal injury, sodium phosphate enemas should be used with extreme caution and reserved for appropriate indications. Consider alternative bowel preparation agents, especially in at-risk populations.
---
Please verify the current prescribing information for the specific product being used, as recommendations may vary.
